Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia

Clinical trial NCT03346668 · COMPLETED

Trial details

NCT number: NCT03346668
Sponsor: University of Minnesota
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Scarring Alopecia Frontal Fibrosing Alopecia Lichen Planopilaris Central Centrifugal Cicatricial Alopecia Central Centrifugal Scarring Alopecia

Start date: 2016-01-28
Primary completion: 2021-10-11
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.